Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | YH32367 |
Trade Name | |
Synonyms | YH 32367|YH-32367|ABL105|AB L105|AB-L105 |
Drug Descriptions |
YH32367 (ABL105) is a bispectific antibody targeting ERBB2 (HER2) and TNFRSF9 (4-1BB), which potentially enhances antitumor immune response and inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 1139). |
DrugClasses | HER2 (ERBB2) Antibody 76 TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
YH32367 | YH32367 | 0 | 1 |